Primary HPV Screening vs Cotesting for Cervical Cancer-Reference-Cited by-同舟云学术

Primary HPV Screening vs Cotesting for Cervical Cancer

Published:2023-12-05 Issue:21 Volume:330 Page:2121
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Brakebill Annika¹,Morgan Anna¹,Lieberman Richard W.²

Affiliation:

1. University of Michigan Medical School, Ann Arbor

2. Departments of Obstetrics & Gynecology and Pathology, University of Michigan, Ann Arbor

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2812488/jama_brakebill_2023_le_230121_1701196165.89491.pdf

Reference5 articles.

1. Cervical cancer screening: a review.;Perkins;JAMA,2023

2. Tumor typing of endocervical adenocarcinoma: contemporary review and recommendations from the International Society of Gynecological Pathologists.;Stolnicu;Int J Gynecol Pathol,2021

3. Contributions of liquid-based (Papanicolaou) cytology and human papillomavirus testing in cotesting for detection of cervical cancer and precancer in the United States.;Kaufman;Am J Clin Pathol,2020

4. Screening for cervical cancer: US Preventive Services Task Force recommendation statement.;Curry;JAMA,2018

5. KFF. The HPV vaccine: access and use in the US. Published July 12, 2021. Accessed September 1, 2023. https://www.kff.org/womens-health-policy/fact-sheet/the-hpv-vaccine-access-and-use-in-the-u-s/

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation-related differentially expressed genes as potential prognostic biomarkers for cervical cancer;Heliyon;2024-09

2. Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens;Frontiers in Public Health;2024-07-19

3. Editorial: The association between viral infection and human cancers;Frontiers in Microbiology;2024-02-02